Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE3
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
- Status
- COMPLETED
- Phase
- PHASE2
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
- Status
- COMPLETED
- Phase
- PHASE3
Lapatinib and Trastuzumab With or Without Endocrine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Multiple Phase I Combinations
- Status
- COMPLETED
- Phase
- PHASE1
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
- Status
- TERMINATED
- Phase
- PHASE3
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2